Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late ascending
US (SEER+NPCR) 1 12.0 (11.9, 12.0) N/A 45,317 64.4
Maine 6 14.2 (13.4, 15.0) 3 (1, 12) 277 71.1
South Dakota 6 13.6 (12.6, 14.7) 5 (1, 27) 145 70.4
Maryland 6 12.5 (12.1, 12.8) 22 (12, 30) 891 69.9
Iowa 3 14.8 (14.2, 15.3) 1 (1, 5) 578 69.8
Kentucky 3 13.6 (13.1, 14.0) 7 (2, 15) 739 69.7
West Virginia 6 13.6 (12.9, 14.3) 6 (1, 19) 341 69.7
Wisconsin 6 14.3 (13.9, 14.7) 2 (1, 6) 1,048 69.7
Ohio 6 13.1 (12.9, 13.4) 9 (5, 17) 1,928 69.5
Colorado 6 11.5 (11.1, 11.9) 34 (27, 38) 713 69.4
Montana 6 12.3 (11.5, 13.2) 25 (5, 37) 174 69.4
Idaho 3 13.1 (12.4, 13.8) 10 (3, 29) 268 69.1
North Carolina 6 12.1 (11.9, 12.4) 29 (18, 32) 1,516 69.0
Utah 3 12.4 (11.8, 13.0) 23 (8, 33) 350 69.0
Missouri 6 12.6 (12.3, 13.0) 16 (9, 28) 968 68.7
Pennsylvania 6 13.4 (13.2, 13.7) 8 (4, 13) 2,265 67.8
Michigan 6 12.6 (12.3, 12.9) 19 (12, 28) 1,573 67.5
Vermont 6 12.4 (11.3, 13.5) 24 (4, 39) 109 67.3
Kansas 6 12.6 (12.1, 13.2) 17 (7, 31) 433 67.2
North Dakota 6 12.5 (11.4, 13.6) 21 (3, 38) 109 66.8
California 3 11.8 (11.7, 12.0) 30 (26, 34) 5,174 66.7
Massachusetts 3 12.6 (12.3, 12.9) 18 (10, 28) 1,073 66.7
Louisiana 3 12.3 (11.9, 12.7) 26 (13, 33) 663 66.6
Delaware 6 11.6 (10.8, 12.5) 32 (13, 41) 149 66.3
Georgia 3 11.6 (11.3, 11.9) 33 (28, 37) 1,318 66.3
Illinois 3 12.5 (12.3, 12.8) 20 (12, 28) 1,885 66.3
Oregon 6 11.8 (11.4, 12.2) 31 (21, 37) 619 65.5
Nebraska 6 12.6 (12.0, 13.3) 15 (5, 33) 285 65.1
Rhode Island 6 12.2 (11.3, 13.1) 28 (7, 38) 163 65.0
Washington 5 12.3 (11.9, 12.6) 27 (15, 32) 1,072 65.0
Virginia 6 10.6 (10.3, 10.9) 40 (36, 43) 1,061 64.2
Connecticut 3 13.0 (12.6, 13.5) 11 (4, 24) 602 64.1
Minnesota 6 14.0 (13.5, 14.4) 4 (1, 9) 942 63.9
Oklahoma 6 10.8 (10.4, 11.3) 38 (34, 43) 500 63.8
South Carolina 6 9.9 (9.5, 10.3) 43 (41, 47) 634 63.8
Alabama 6 9.6 (9.2, 9.9) 45 (42, 48) 579 63.1
Alaska 6 11.2 (10.1, 12.4) 37 (12, 45) 81 63.0
Arkansas 6 11.4 (10.9, 11.9) 36 (26, 39) 427 63.0
Wyoming 6 9.9 (8.8, 11.0) 44 (33, 48) 70 62.5
New Hampshire 6 12.9 (12.1, 13.7) 14 (3, 32) 233 62.3
Hawaii 3 9.3 (8.7, 10.0) 46 (42, 48) 173 62.2
New York 3 13.0 (12.8, 13.2) 13 (8, 19) 3,106 62.1
Arizona 6 9.1 (8.8, 9.4) 47 (45, 48) 813 62.0
District of Columbia 6 9.0 (8.0, 10.1) 48 (40, 49) 62 61.8
Mississippi 6 10.1 (9.6, 10.6) 42 (38, 46) 353 61.8
Tennessee 6 10.8 (10.4, 11.1) 39 (36, 42) 887 61.8
New Jersey 3 13.0 (12.7, 13.3) 12 (6, 21) 1,422 61.2
Texas 3 10.4 (10.2, 10.6) 41 (38, 43) 2,993 60.7
New Mexico 3 7.7 (7.2, 8.2) 49 (48, 49) 203 54.0
Florida 6 11.4 (11.3, 11.6) 35 (30, 37) 3,380 52.9
Puerto Rico 6 5.9 (5.6, 6.3) N/A 237 42.4
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 02/23/2024 10:58 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top